[Federal Register Volume 78, Number 226 (Friday, November 22, 2013)]
[Notices]
[Pages 70043-70044]
[FR Doc No: 2013-28129]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2013-0703; FRL-9902-97]

Pesticide Product Registration; Receipt of an Application for a
New Active Ingredient

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: EPA has received an application to register a pesticide
product containing an active ingredient not included in any previously
registered pesticide product. Pursuant to the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA), EPA is hereby providing notice
of receipt and opportunity to comment on the application.

DATES: Comments must be received on or before December 23, 2013.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2013-0703, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any

information you consider to be Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Robert McNally, Biopesticides and
Pollution Prevention Division (7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>; email
address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period
deadline identified.

II. Registration Application

    EPA has received an application to register a pesticide product
containing an active ingredient not included in any previously
registered pesticide product. Pursuant to the provisions of FIFRA
section 3(c)(4), EPA is hereby providing notice of receipt and
opportunity to comment on the application. Notice of receipt of the
application does not imply a decision by the Agency on the application.
    File Symbol: 68467-EN. Applicant: Dow AgroSciences LLC, 9330
Zionsville Rd., Indianapolis, IN 46268. Product name: DAS-81419-2
Soybean. Active ingredients: Bacillus thuringiensis Cry1Ac protein
expressed in soybean and Bacillus thuringiensis Cry1F protein expressed
in soybean. Proposed classification/Use: Plant-incorporated Protectant
(PIP).

List of Subjects

    Environmental protection, Pesticides and pest.

    Dated: November 8, 2013.
Robert McNally,
Director, Biopesticides and Pollution Prevention Division, Office of
Pesticide Programs.
[FR Doc. 2013-28129 Filed 11-21-13; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: July 22, 2009 (Volume 74, Number 139)]
[Notices]
[Page 36190-36191]
[DOCID:fr22jy09-55]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Notice of Membership of Performance Review Board for Senior
Executives (PRB)

July 15, 2009.
    The Federal Energy Regulatory Commission hereby provides notice of

the membership of its Performance Review Board (PRB) for the
Commission's Senior Executive Service (SES) members. The function of
this board is to make recommendations relating to the performance of
senior executives in the Commission. This action is undertaken in
accordance with Title 5, U.S.C., section 4314(c)(4). The Commission's
PRB will remove the following members:
Shelton M. Cannon,
J. Mark Robinson,
Susan J. Court.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-17340 Filed 7-21-09; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 169 (Friday, September 1, 2017)]
[Notices]
[Page 41624]
[FR Doc No: 2017-18548]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-5079]

Determination That NIZORAL (Ketoconazole) Tablets, 200
Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or
Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) has
determined that NIZORAL (ketoconazole) tablets, 200 milligrams (mg),
were not withdrawn from sale for reasons of safety or effectiveness.
This determination means that FDA will not begin procedures to withdraw
approval of abbreviated new drug applications (ANDAs) that refer to
NIZORAL, and it will allow FDA to continue to approve ANDAs that
reference NIZORAL as long as they meet relevant legal and regulatory
requirements.

FOR FURTHER INFORMATION CONTACT: Robin Fastenau, Center for Drug
Evaluation Research, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 6236, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: In 1984, Congress enacted the Drug Price
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417)
(the 1984 amendments), which authorized the approval of duplicate
versions of drug products under an ANDA procedure. ANDA applicants
must, with certain exceptions, show that the drug for which they are
seeking approval contains the same active ingredient in the same
strength and dosage form as the ``listed drug,'' which is a version of
the drug that was previously approved. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    The 1984 amendments include what is now section 505(j)(7) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(7)), which
requires FDA to publish a list of all approved drugs. FDA publishes
this list as part of the ``Approved Drug Products With Therapeutic
Equivalence Evaluations,'' which is known generally as the ``Orange
Book.'' Under FDA regulations, drugs are removed from the list if the
Agency withdraws or suspends approval of the drug's NDA or ANDA for
reasons of safety or effectiveness or if FDA determines that the listed
drug was withdrawn from sale for reasons of safety or effectiveness (21
CFR 314.162).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness. This determination
may be made at any time after the drug has been withdrawn from sale,
but must be made prior to approving an ANDA that refers to the listed
drug (Sec.  314.161 (21 CFR 314.161)). FDA may not approve an ANDA that
does not refer to a listed drug.
    NIZORAL (ketoconazole) tablets, 200 mg, is the subject of NDA 018-
533 and was originally held by Johnson & Johnson Research and
Development, L.L.C., now known as Janssen Research & Development,
L.L.C. (Janssen). It was initially approved on June 12, 1981. NIZORAL
should be used only when other effective antifungal therapy is not
available or tolerated and the potential benefits are considered to
outweigh the potential risks. NIZORAL is indicated for the treatment of
the following systemic fungal infections in patients who have failed or
who are intolerant to other therapies: blastomycosis,
coccidioidomycosis, histoplasmosis, chromomycosis, and
paracoccidioidomycosis.
    In a letter dated May 22, 2008, Janssen, which at that time was
operating as Johnson & Johnson Pharmaceutical Research & Development,
L.L.C., acting on behalf of Ortho-McNeil-Janssen Pharmaceuticals, Inc.,
notified FDA that NIZORAL (ketoconazole) tablets, 200 mg, were being
discontinued and requested withdrawal of NDA 018-533. In the Federal
Register of October 13, 2015 (80 FR 61426), FDA announced that it was
withdrawing approval of NDA 018-533, effective November 12, 2015.
    After reviewing Agency records and based on the information we have
at this time, FDA has determined under Sec.  314.161 that NIZORAL
(ketoconazole) tablets, 200 mg, were not withdrawn for reasons of
safety or effectiveness. We have carefully reviewed our files for
records concerning the withdrawal of NIZORAL (ketoconazole) tablets,
200 mg, from sale. We have also independently evaluated relevant
literature and data for possible postmarketing adverse events. We have
reviewed the available evidence and determined that this drug product
was not withdrawn from sale for reasons of safety or effectiveness.
    Accordingly, the Agency will continue to list NIZORAL
(ketoconazole) tablets, 200 mg, in the ``Discontinued Drug Product
List'' section of the Orange Book. The ``Discontinued Drug Product
List'' delineates, among other items, drug products that have been
discontinued from marketing for reasons other than safety or
effectiveness. FDA will not begin procedures to withdraw approval of
approved ANDAs that refer to NIZORAL. Additional ANDAs that refer to
NIZORAL (ketoconazole) tablets, 200 mg, may also be approved by the
Agency as long as they meet all other legal and regulatory requirements
for the approval of ANDAs. If FDA determines that labeling for this
drug product should be revised to meet current standards, the Agency
will advise ANDA applicants to submit such labeling.

    Dated: August 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-18548 Filed 8-31-17; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 89 (Tuesday, May 9, 2023)]
[Notices]
[Page 29921]
[FR Doc No: 2023-09850]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2023-0294]

Information Collection Request to Office of Management and
Budget; OMB Control Number: 1625-0100

AGENCY: Coast Guard, DHS.

ACTION: Sixty-day notice requesting comments.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
U.S. Coast Guard intends to submit an Information Collection Request
(ICR) to the Office of Management and Budget (OMB), Office of
Information and Regulatory Affairs (OIRA), requesting an extension of
its approval for the following collection of information: 1625-0100,
Advanced Notice of Vessel Arrival; without change. Our ICR describes
the information we seek to collect from the public. Before submitting
this ICR to OIRA, the Coast Guard is inviting comments as described
below.

DATES: Comments must reach the Coast Guard on or before July 10, 2023.

ADDRESSES: You may submit comments identified by Coast Guard docket
number [USCG-2023-0294] to the Coast Guard using the Federal
eRulemaking Portal at https://www.regulations.gov. See the ``Public
participation and request for comments'' portion of the SUPPLEMENTARY
INFORMATION section for further instructions on submitting comments.
    A copy of the ICR is available through the docket on the internet
at https://www.regulations.gov. Additionally, copies are available
from: Commandant (CG-6P), Attn: Paperwork Reduction Act Manager, U.S.
Coast Guard, 2703 Martin Luther King, Jr. Ave. SE, Stop 7710,
Washington, DC 20593-7710.

FOR FURTHER INFORMATION CONTACT: A.L. Craig, Office of Privacy
Management, telephone<PHONE_NUMBER>, or fax<PHONE_NUMBER>, for questions
on these documents.

SUPPLEMENTARY INFORMATION:

Public Participation and Request for Comments

    This notice relies on the authority of the Paperwork Reduction Act
of 1995; 44 U.S.C. 3501 et seq., chapter 35, as amended. An ICR is an
application to OIRA seeking the approval, extension, or renewal of a
Coast Guard collection of information (Collection). The ICR contains
information describing the Collection's purpose, the Collection's
likely burden on the affected public, an explanation of the necessity
of the Collection, and other important information describing the
Collection. There is one ICR for each Collection.
    The Coast Guard invites comments on whether this ICR should be
granted based on the Collection being necessary for the proper
performance of Departmental functions. In particular, the Coast Guard
would appreciate comments addressing: (1) the practical utility of the
Collection; (2) the accuracy of the estimated burden of the Collection;
(3) ways to enhance the quality, utility, and clarity of information
subject to the Collection; and (4) ways to minimize the burden of the
Collection on respondents, including the use of automated collection
techniques or other forms of information technology.
    In response to your comments, we may revise this ICR or decide not
to seek an extension of approval for the Collection. We will consider
all comments and material received during the comment period.
    We encourage you to respond to this request by submitting comments
and related materials. Comments must contain the OMB Control Number of
the ICR and the docket number of this request, [USCG-2023-0294], and
must be received by July 10, 2023.

Submitting Comments

    We encourage you to submit comments through the Federal eRulemaking
Portal at https://www.regulations.gov. If your material cannot be
submitted using https://www.regulations.gov, contact the person in the
FOR FURTHER INFORMATION CONTACT section of this document for alternate
instructions. Documents mentioned in this notice, and all public
comments, are in our online docket at https://www.regulations.gov and
can be viewed by following that website's instructions. Additionally,
if you go to the online docket and sign up for email alerts, you will
be notified when comments are posted.
    We accept anonymous comments. All comments received will be posted
without change to https://www.regulations.gov and will include any
personal information you have provided. For more about privacy and
submissions in response to this document, see DHS's eRulemaking System
of Records notice (85 FR 14226, March 11, 2020).

Information Collection Request

    Title: Advanced Notice of Vessel Arrival.
    OMB Control Number: 1625-0100.
    Summary: The statute 46 U.S.C. 70001 authorizes the Coast Guard to
require pre-arrival messages from any vessel entering a port or place
in the United States.
    Need: This information is required under 33 CFR 146 and 33 CFR 160
subpart C to control vessel traffic, develop contingency plans, and
enforce regulations.
    Forms: None.
    Respondents: Owners and operators of vessels and facilities.
    Frequency: On occasion.
    Hour Burden Estimate: The estimated burden has increased from
104,560 hours to 202,021 hours a year; due to an increase in the
estimated annual number of responses.
    Authority: The Paperwork Reduction Act of 1995; 44 U.S.C. chapter
35, as amended.

    Dated: May 4, 2023.
Kathleen Claffie,
Chief, Office of Privacy Management, U.S. Coast Guard.
[FR Doc. 2023-09850 Filed 5-8-23; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register: March 29, 2006 (Volume 71, Number 60)]
[Notices]
[Page 15731-15732]
[DOCID:fr29mr06-77]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

EPA-HQ-OPP-2005-0061; FRL-7771-4]

Azinphos-methyl; Order to Amend Registrations to Terminate
Certain Uses

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the order to amend registrations to
terminate certain uses, voluntarily requested by the registrant(s) and
accepted by the Agency, of end-use products containing the pesticide
azinphos-methyl, pursuant to section 6(f)(1) of the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended. This
cancellation order follows an August 17, 2005, Federal Register Notice
of Receipt of Requests (70 FR 48395) (FRL-7733-3) from the azinphos-
methyl registrants to amend their product registrations to terminate
certain uses of azinphos-methyl from their product registrations. In
the August 17, 2005 Notice, EPA indicated that it would issue an order
implementing the amendments to terminate uses, unless the Agency
received substantive comments within the 60-day comment period that
would merit its further review of these requests. The Agency received
two comments on the notice. These comments have been reviewed and taken
into consideration in the Agency's decision to proceed with this
termination order, and a response was sent to each commentor and placed
in the public docket. EPA's decision is discussed in Unit III. of this
notice. Any distribution, sale, or use of the azinphos-methyl products
subject to this cancellation order is permitted only in accordance with
the terms of this order, including any existing stocks provisions.

DATES: The cancellations are effective March 29, 2006.

FOR FURTHER INFORMATION CONTACT: Diane Isbell, Special Review and
Reregistration Division (7508C), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>; fax
number:<PHONE_NUMBER>; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.

B. How Can I Get Copies of this Document and Other Related Information?

    1. Docket. EPA has established a docket for this action under
Docket identification number (ID) EPA-HQ-OPP-2006-0061; FRL-7771-4.
Publicly available docket materials are available either electronically
at http://www.regulations.gov or in hard copy at the Public Information

and Records Integrity Branch (PIRIB), Rm. 119, Crystal Mall 2,
1801 S. Bell St., Arlington, VA. This Docket Facility is open from 8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The
Docket telephone number is<PHONE_NUMBER>.

    2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/.

II. What Action is the Agency Taking?

    In May of 2002, Bayer CropScience, Makheteshim Chemical Works,
Gowan Company, and Micro-Flo Corporation signed a Memorandum of
Agreement with EPA implementing the provisions of the Azinphos-methyl
Interim Reregistration Eligibility Decision by dividing the universe of
uses into three groups. Group 1 contained 23 crops with little use that
were deleted from product labels immediately. Group 2 consists of the
seven uses that are the subject of this order, and are scheduled to be
phased out in September, 2006. The Group 2 uses included: caneberries,
cotton, cranberries, peaches/nectarines, potatoes, and Southern pine
seed orchards. Group 3 is comprised of the only 10 remaining uses which
have time-limited registrations that are currently in the process of
being reevaluated. This Order implements the Agency's decision on the
Group 2 uses for azinphos-methyl.
    Table 1 includes the product registration numbers, the names of the
products requested to be terminated and the name of the registrants in
sequence by EPA number.

 Table 1.-- Azinphos-methyl Product Registration Amendments to Terminate
                                  Uses
------------------------------------------------------------------------
        Registration No.             Product name           Company
------------------------------------------------------------------------
264-733                           Guthion Solupak     Bayer Cropscience
                                   50% Wettable
                                   Powder
                                   Insecticide
------------------------------------------------------------------------
10163-78                          Gowan Azinphos-M    Gowan Company
10163-138.......................   50 WSB
10163-139.......................  Gowan Azinphos-M
10163-180.......................   35 WP.
                                  Gowan Azinphos-M
                                   35 WSB.
                                  Gowan Azinphos 50
                                   PVA.
------------------------------------------------------------------------
11678-53                          Cotnion-Methyl      Makhteshim
66222-11........................  Azinphos-methyl      Chemical Works
                                   50W.
------------------------------------------------------------------------
51036-164                         Azinphos-methyl     Microflo Company
                                   50W
------------------------------------------------------------------------

    Table 2 includes the names and addresses of record for the
registrants that requested use terminations for their products, in
sequence by EPA company number.

       Table 2.-- Registrants of Amended Azinphos-methyl Products
------------------------------------------------------------------------
              EPA Company No.                 Company Name and Address
------------------------------------------------------------------------
264                                         Bayer CropScience
                                            2 T.W. Alexander Drive
                                            Research Triangle Park,
                                             North Carolina 27709
------------------------------------------------------------------------
10163                                       Gowan Company
                                            P.O. Box 5569
                                            Yuma, Arizona 85366-5569
------------------------------------------------------------------------
11678                                       Makhteshim Chemical Works
66222.....................................  4515 Falls of Neuse Road,
                                             Suite 300
                                            Raleigh, North Carolina
                                             27609
------------------------------------------------------------------------
51036                                       Micro-Flo Corporation, LLC
                                            Oak Court Drive
                                            Memphis, Tennessee 38117
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    During the public comment period provided, EPA received two
comments in response to the August 17, 2005 Federal Register notice
announcing the Agency's receipt of the requests to terminate certain
uses of azinphos-methyl. The Agency has responded individually to each
of those comments and placed copies of the responses in the public
docket.

IV. Cancellation Order

    Pursuant to FIFRA section 6(f), EPA hereby approves the requested
cancellations and amendments to terminate uses of azinphos-methyl
registrations identified in Table 1 of Unit II. Accordingly, the Agency
orders that the azinphos-methyl product registrations identified in
Table 1 of Unit II. are hereby amended to terminate the affected uses.
Any distribution, sale, or use of the products identified in Table 1 of
Unit II. in a manner inconsistent with this order, including any of the
provisions for disposition of existing stocks set forth below in Unit
VI., will be considered a violation of FIFRA.

V. What is the Agency's Authority for Taking this Action?

    Section 6(f)(1) of FIFRA provides that a registrant of a pesticide
product may at any time request that any of its pesticide registrations
be canceled or amended to terminate one or more uses. FIFRA further
provides that, before acting on the request, EPA must publish for
public comment a notice of receipt of any such request in the Federal
Register. Thereafter, following the public comment period, the
Administrator may act on such a request.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action.
    The Agency proposed to include the following provisions for the
treatment of any existing stocks of the azinphos-methyl end-use
products identified in Table 1: The distribution or sale of these
products is permitted until March 31, 2006. The use of existing stocks
of these products in the United States is permitted until September 30,
2006 provided such use is in a manner consistent with the labeling of
these products.
    Section III B 3 of the 2002 Memorandum of Agreement provides for
extension of sale and distribution of existing stocks of end-use
products by an equal period of time if EPA issues the termination order
after August 31, 2005. Distribution or sale of existing stocks of end-
use products, is allowed until March 31, 2006. Use of these end-use
products is allowed until September 30, 2006, to avoid difficulties and
confusion to growers that could result from a mid-use season existing
stocks date. The existing stocks dates in this notice for end-use
products are compatible with those established for the corresponding
manufacturing-use products.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: March 23, 2006.
Debra Edwards,
Director, Special Review and Reregistration Division, Office of
Pesticide Programs.
[FR Doc. E6-4569 Filed 3-28-06; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register Volume 77, Number 48 (Monday, March 12, 2012)]
[Notices]
[Page 14519]
[FR Doc No: 2012-5881]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9645-5]

Meeting of the EPA's Children's Health Protection Advisory
Committee (CHPAC)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the provisions of the Federal Advisory Committee
Act, Public Law 92-463, notice is hereby given that the next meeting of
the Children's Health Protection Advisory Committee (CHPAC) will be
held March 28 and 29 at Mount Vernon Place, 900 Massachusetts Avenue,
Washington, DC. The CHPAC was created to advise the Environmental
Protection Agency on science, regulations, and other issues relating to
children's environmental health.

DATES: The Children's Health Protection Advisory Committee will meet
March 28 and 29, 2012.

ADDRESSES: Mount Vernon Place, 900 Massachusetts Avenue, Washington,
DC.

FOR FURTHER INFORMATION CONTACT: Martha Berger, Office of Children's
Health Protection, USEPA, MC 1107T, 1200 Pennsylvania Avenue NW.,
Washington, DC 20460,<PHONE_NUMBER><EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The meetings of the CHPAC are open to the
public. No registration is required. Preliminary agenda includes
discussion of an advice letters on lead regulations, social
determinants of health and children's environmental health, and EPA's
Risk Assessment Forum and children's health projects. The full agenda
will be posted at www.epa.gov/children.
    Access: For information on access or services for individuals with
disabilities, please contact Martha Berger at<PHONE_NUMBER> or
<EMAIL_ADDRESS>
    Dated: February 21, 2012.
Martha Berger,
Designated Federal Official.
[FR Doc. 2012-5881 Filed 3-9-12; 8:45 am]
BILLING CODE 6560-50-P